Antiseptic therapy with a polylacticacid-acetic acid matrix in burns

Wound Repair and Regeneration

Volumn 18, Issue 5, 2010, Pages 439-444

  Ryssel, Henning ^a,b   Gazyakan, Emre ^a,b   Germann, Günter ^a,b   Hellmich, Susanne ^a,b   Riedel, Katrin ^a,b   Reichenberger, Matthias A ^a,b   Radu, Christian A ^a,b  

^a BG Trauma Center Ludwigshafen   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; POLYLACTIC ACID; SULFADIAZINE SILVER;

ARTICLE; BACTERIAL COLONIZATION; BACTERIUM IDENTIFICATION; BURN; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; GRAFT REJECTION; HUMAN; INCIDENCE; MALE; PRIORITY JOURNAL; RISK REDUCTION; SEPSIS; TREATMENT RESPONSE; WOUND DRESSING; WOUND HEALING IMPAIRMENT; WOUND INFECTION;

ACETIC ACID; ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS, LOCAL; BURNS; DEBRIDEMENT; FEMALE; HUMANS; MALE; MIDDLE AGED; SKIN; TREATMENT OUTCOME; WOUND HEALING; WOUND INFECTION; YOUNG ADULT;

EID: 77956643232     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2010.00610.x     Document Type: Article

References (31)

1. Edwards-Jones V, Greenwood JE. What's new in burn microbiology?: James Laing memorial prize essay 2000. Burns 2003 29: 15 24.
2. Bjarnsholt T, Kirketerp-Moller K, Østrup Jensen P, Madsen KG, Phipps R, Krogfelt K, Mølby N, Givskov M. Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen 2008 16: 2 10.
3. Atiyeh BS, Costagliola M, Hayek SN, Dibo SA. Effect of silver on burn wound infection control and healing: review of the literature. Burns 2007 33: 139 148.
4. Wang XW, Wang NZ, Zhang OZ, Zapta-Sirvent RL, Davies JWL. Tissue deposition of silver following topical use of silver sulphadiazine in extensive burns. Burns Incl Therm Inj 1985 1: 197 201.
5. Edwards-Jones V, Dawson MM, Childs CA. Survey into TSS in UK burns units. Burns 2000 26: 323 333.
6. Ryssel H, Germann G, Radu C, Kloeters O, Hrabowski M, Riedel K. Suprathel®-acetic acid-matrix: in vitro model for local antiseptic treatment. Advances in Skin & Wound Care, (in press).
7. Cooper RA, Molan PC. The use of honey as antiseptic in managing Pseudomonas infection. J Wound Care 1999 8: 161 164.
8. Starley IF, Mohammed P, Schneider G, Bickerler SW. The treatment of paediatric burns using topical papaya. Burns 1999 25: 636 639.
9. Lardner A. The effect of extracellular pH on immune function. J Leukoc Biol 2001 69: 522 530.
10. Ryssel H, Kloeters O, Germann G, Schäfer T, Wiedemann G, Oehlbauer M. The antimicrobial effect of acetic acid - an alternative to common local antiseptics? Burns 2009 25: 695 700.
11. Fux CA, Costerton JW, Stewart PS, Stoodley P. Survival strategies of infectious biofilms. Trends Microbiol 2005 13: 34 40.
12. Ross DA, Phipps AJ, Clarke JA. The use of cerium nitrate - silver sulphadiazine as a topical burns dressings. Br J Plast Surg 1993 46: 582 584.
13. Gravante G, Caruso R, Sorge R, Nicoli F, Gentile P, Cervelli V. Nanocrystalline silver: a systematic review of randomized trials conducted on burned patients and an evidence-based assessment of potential advantages over older silver formulations. Ann Plast Surg 2009 63: 201 205.
14. Fuller FW. The side effects of silver sulfadiazine. J Burn Care Res 2009 30: 464 470.
15. Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 2009 27: 76 83.
16. Huang Y, Li X, Liao Z, Zhang G, Liu Q, Tang J, Peng Y, Liu X, Luo Q. A randomized comparative trial between Acticoat and SD-Ag in the treatment of residual burn wounds, including safety analysis. Burns 2007 33: 161 166.
17. Morones Jr. Elechiguerra JL, Camacho A, Ramirez JT. The bacterial effect of silver nanoparticles. Nanotechnology 2005 16: 2346 2353.
18. Pal S, Tak YK, Song JM. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the Gram-negative bacterium Escherichia coli. Appl Environ Microbiol 2007 73: 1712 1720.
19. Panacek A, Kvítek L, Prucek R, Kolar M, Vecerova R, Pizúrova N, Sharma VK, Nevecna T, Zboril R. Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity. J Phys Chem B 2006 110: 16248 16253.
20. Ip M, Lui SL, Poon VK, Lung I, Burd A. Antimicrobial activities of silver dressings: an in vitro comparison. J Med Microbiol 2006 55: 59 63.
21. Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, Schilter HC, Rolph MS, Mackay F, Artis D, Xavier RJ, Teixeira MM, Mackay CR. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009 461: 1282 1286.
22. Edwards-Jones V, Childs C, Foster HA. A comparison of phenotypic properties of isolates of S. aureus from burned patients and other patient groups. Burns 1996 22: 384 389.
23. Federle MJ, Bassler BL. Interspecies communication in bacteria. J Clin Invest 2003 112: 1291 1299.
24. Roos K, Håkansson EG, Holm S. Effect of recolonisation with "interfering" a-streptococci on recurrences of acute and secretory otitis media in children: randomized placebo controlled trial. BMJ 2001 322: 1 4.
25. Harder B. Germs that do a body good. Sci News 2002 161: 72 7.
26. Reid G, Jass J, Sebulsky MT, McCormicK JK. Potential uses of probiotic in clinical practice. Clin Microbiol Rev 2002 16: 658 672.
27. Valde'z JC, Peral M, Rachid M, Santana M, Perdigo'n G. Interference of Lactobacillus plantarum on Pseudomonas aeruginosa in vitro and in infected burns. The potential use of probiotic in the wound treatment. Clin Microbiol Infect 2005 11: 472 479.
28. Gan BS, Kim J, Reid G, Cadieux P, Howard JC. Lactobacillus fermentum RC-14 inhibits Staphylococcus aureus infection of surgical implants in rats. J Infect Dis 2002 185: 1369 1372.
29. Soares de Macedo JL, Barberino Santos J. Nosocomial infections in a Brazilian burn unit. Burns 2006 32: 477 481.
30. Sasakawa C, Hacker J. Host-microbe interaction: bacteria. Curr Opin Microbiol 2006 9: 1 4.
31. Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, Schilter HC, Rolph MS, Mackay F, Artis D, Xavier RJ, Teixeira MM, Mackay CR. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009 29: 1282 1286.